AYTU BIOPHARMA INC (AYTU) Stock Balance Sheet
NASDAQ:AYTU • US0547548588
Current stock price
2.61 USD
+0.02 (+0.77%)
At close:
2.5479 USD
-0.06 (-2.38%)
After Hours:
| MRQ (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 30.02M | 30.95M | 20.01M | 23.00M | 19.40M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 30.92M | 31.16M | 23.62M | 28.90M | 21.70M | |||
| Inventories | 8.66M | 11.43M | 12.63M | 12.00M | 10.80M | |||
| Other Current Assets | 6.64M | 5.64M | 5.63M | 8.90M | 8.00M | |||
| Total Current Assets | 76.24M | 79.18M | 61.89M | 72.80M | 59.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.44M | 1.59M | 1.52M | 3.90M | 6.30M | |||
| Goodwill | N/A | N/A | N/A | N/A | 0.00 | |||
| Intangibles | 43.58M | 42.20M | 52.45M | 59.00M | 70.60M | |||
| Other Non-Current Assets | 738.00K | 1.20M | 2.23M | 800.00K | 800.00K | |||
| Total Non-Current Assets | 45.76M | 45.00M | 56.20M | 63.70M | 77.70M | |||
| TOTAL ASSETS | 122.00M | 124.18M | 118.09M | 136.50M | 137.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 9.07M | 9.06M | 2.40M | 1.60M | 3.80M | |||
| Current Portion Of LT Debt. | 1.86M | 1.86M | 1.86M | 100.00K | 100.00K | |||
| Accrued Expenses | 34.05M | 32.62M | 29.32M | 37.00M | 35.90M | |||
| Accounts Payable | 20.56M | 16.28M | 20.40M | 24.50M | 20.50M | |||
| Other Current Liabilities | 18.00K | 3.24M | 8.25M | 5.80M | 4.10M | |||
| Total Current Liabilities | 65.56M | 63.06M | 62.23M | 69.00M | 64.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 10.00M | 10.89M | 10.88M | 14.70M | 14.30M | |||
| Other Non-Current Liabilities | 32.24M | 31.25M | 17.27M | 13.40M | 12.80M | |||
| Total Non-Current Liabilities | 42.24M | 42.15M | 28.15M | 28.10M | 27.10M | |||
| TOTAL LIABILITIES | 107.80M | 105.21M | 90.38M | 97.10M | 91.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -342.15M | -333.54M | -319.97M | -304.10M | -288.50M | |||
| Additional Paid In Capital | 356.35M | 352.50M | 347.69M | 343.50M | 334.60M | |||
| Common Shares | 1.00K | 1.00K | 1.00K | 0.00 | 0.00 | |||
| Shares Outstanding | 10.73M | 8.98M | 5.97M | 5.50M | 1.90M | |||
| Tangible Book Value per Share | -2.74 | -2.59 | -4.14 | -3.56 | -12.89 | |||
| Total Shareholders' Equity | 14.20M | 18.97M | 27.72M | 39.40M | 46.10M | |||
| TOTAL LIABILITIES AND EQUITY | 122.00M | 124.18M | 118.09M | 136.50M | 137.60M | |||
| Statistics | ||||||||
| Debt/Equity | 1.34 | 1.05 | 0.48 | 0.41 | 0.39 | |||
| Current Ratio | 1.16 | 1.26 | 0.99 | 1.06 | 0.93 | |||
| Return On Assets (ROA) | -20.04% | -10.92% | -13.42% | -12.53% | -79.07% | |||
| Return On Equity (ROE) | -172.12% | -71.51% | -57.17% | -43.40% | -236.01% | |||
| Return On Invested Capital (ROIC) | N/A | 2.86% | 0.77% | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | 5.11% | 1.17% | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21